| 发明名称 |
THERAPEUTIC USE OF QUINONOID DERIVATIVES OF CANNABINOIDS |
| 摘要 |
<p>The present invention relates to cannabinoic quinone compounds, and especially to their medical use. In particular five cannabinoic quinones, designated HU-331, HU-336, HU-345, HU-395 and HU-396 are herein described as active agents in pharmaceutical compositions. Said compounds and compositions thereof are intended for the treatment of inflammatory, infectious, auto-immune and particularly hyperproliferative disorders. Thus, the compounds of the invention may be used as anti-tumor agents, or for the treatment of cancer. Furthermore, three of these compounds, HU-345, HU-395 and HU-396, are novel cannabinoic quinones and thus are also claimed herein.</p> |
| 申请公布号 |
WO2005067917(A1) |
申请公布日期 |
2005.07.28 |
| 申请号 |
WO2005IL00053 |
申请日期 |
2005.01.14 |
| 申请人 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW;MECHOULAM, RAPHAEL;KOGAN, NATALYA M.;RABINOWITZ, RUTH;SCHLESINGER, MICHAEL |
发明人 |
MECHOULAM, RAPHAEL;KOGAN, NATALYA M.;RABINOWITZ, RUTH;SCHLESINGER, MICHAEL |
| 分类号 |
A61K31/122;A61K31/352;C07C50/30;C07D311/80;(IPC1-7):A61K31/352;A61P37/00;A61P35/00;A61P33/02;A61P33/00;A61P29/00;A61P17/06 |
主分类号 |
A61K31/122 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
